Literature DB >> 16212244

Formulation of microemulsion systems for transdermal delivery of aceclofenac.

Jaehwi Lee1, Yoonjin Lee, Jongseok Kim, Mikyeong Yoon, Young Wook Choi.   

Abstract

An ONW microemulsion system was developed to enhance the skin permeability of aceclofenac. Of the oils studied, Labrafil M 1944 CS was chosen as the oil phase of the microemulson, as it showed a good solubilizing capacity. Pseudo-ternary phase diagrams were constructed to obtain the concentration range of oil, surfactant, Cremophor ELP, and co-surfactant, ethanol, for micoemulsion formation. Eight different formulations with various values of oil of 6-30%, water of 0-80%, and the mixture of surfactant and co-surfactant (at the ratio of 2) of 14-70%. The in vitro transdermal permeability of aceclofenac from the microemulsions was evaluated using Franz diffusion cells mounted with rat skin. The level of aceclofenac permeated was analyzed by HPLC and the droplet size of the microemulsions was characterized using a Zetasizer Nano-ZS. Terpenes were added to the microemulsions at a level of 5%, and their effects on the skin permeation of aceclofenac were investigated. The mean diameters of the microemulsions ranged between approximately 10-100 nm, and the skin permeability of the aceclofenac incorporated into the microemulsion systems was 5-fold higher than that of the ethanol vehicle. Of the various terpenes added, limonene had the best enhancing ability. These results indicate that the microemulsion system studied is a promising tool for the percutaneous delivery of aceclofenac.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16212244     DOI: 10.1007/bf02977408

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  12 in total

1.  Microemulsion microstructure influences the skin delivery of an hydrophilic drug.

Authors:  Wafa Naoui; Marie-Alexandrine Bolzinger; Bernard Fenet; Jocelyne Pelletier; Jean-Pierre Valour; Rafik Kalfat; Yves Chevalier
Journal:  Pharm Res       Date:  2011-03-25       Impact factor: 4.200

2.  Formulation of microemulsion systems for dermal delivery of silymarin.

Authors:  Vipaporn Panapisal; Sawitree Charoensri; Angkana Tantituvanont
Journal:  AAPS PharmSciTech       Date:  2012-02-16       Impact factor: 3.246

3.  Design and evaluation of microemulsion gel system of nadifloxacin.

Authors:  Ujwala Shinde; Sharda Pokharkar; Sheela Modani
Journal:  Indian J Pharm Sci       Date:  2012-05       Impact factor: 0.975

4.  Formulation Development and in vitro Characterization of Proliposomes for Topical Delivery of Aceclofenac.

Authors:  Vandana Gupta; Ashok K Barupal; Suman Ramteke
Journal:  Indian J Pharm Sci       Date:  2008-11       Impact factor: 0.975

5.  Preparation and in vivo evaluation of indomethacin loaded true nanoemulsions.

Authors:  Faiyaz Shakeel; Wafa Ramadan; Huda M Gargum; Rajinder Singh
Journal:  Sci Pharm       Date:  2009-11-23

6.  Formulation and evaluation of guggul lipid nanovesicles for transdermal delivery of aceclofenac.

Authors:  Praveen Kumar Gaur; Shikha Mishra; Vidhu Aeri
Journal:  ScientificWorldJournal       Date:  2014-02-06

7.  Formulation of topical bioadhesive gel of aceclofenac using 3-level factorial design.

Authors:  Sanjay Singh; Rabinarayan Parhi; Anuj Garg
Journal:  Iran J Pharm Res       Date:  2011       Impact factor: 1.696

Review 8.  Topical delivery of aceclofenac: challenges and promises of novel drug delivery systems.

Authors:  Kaisar Raza; Manish Kumar; Pramod Kumar; Ruchi Malik; Gajanand Sharma; Manmeet Kaur; O P Katare
Journal:  Biomed Res Int       Date:  2014-06-18       Impact factor: 3.411

9.  Nanostructured Lipid Carriers (NLC)-Based Gel for the Topical Delivery of Aceclofenac: Preparation, Characterization, and In Vivo Evaluation.

Authors:  Dilip Patel; Sandipan Dasgupta; Sanjay Dey; Y Roja Ramani; Subhabrata Ray; Bhaskar Mazumder
Journal:  Sci Pharm       Date:  2012-06-18

10.  Overcoming the cutaneous barrier with microemulsions.

Authors:  Luciana B Lopes
Journal:  Pharmaceutics       Date:  2014-02-28       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.